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Cardiovascular disease (CVD) is the largest
cause of mortality in the world with around
17.7 million victims each year 1 CVDs
include coronary heart disease, ischemic
heart disease, rheumatic heart disease,
cardiomyopathies, and other diseases
involving the heart and circulatory system.
However, in contrast to the progress made in
high-income countries, the burden of CVD
and other noncommunicable diseases have
only continued to rise significantly in low and
middle-income countries, especially India. It
is estimated that nearly 80% of CVDs will be
burdened by developing countries by
2020.2 Interestingly, India has been

disproportionately impacted by these CVDs.
In India, the average age of 59 for heart
failure patients is approximately ten years
younger than the average age for heart failure
(HF) patients in South America and
China 3 In contrast to most western countries,
HF is prevalent in both the young and elderly
in India.4 Moreover, India’s estimated agestandardized death rate of 272 per 100,000
population due to CVDs is greater than the
global average of 235 per 100,000
population5Both environmental and genetic
factors are argued to contribute to this
increased CVD susceptibility. 6 India has
begun to research and implement innovative
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policies and interventions to help tackle this
and achieve the WHO target goal of a 25%
reduction in premature deaths from
noncommunicable diseases by 2025.

include CVD awareness campaigns,
increased preventive health screening, school
education programs, expanded insurance
coverage, increased funding for CVD
research, and more.

General Policies and Interventions

In regards to clinical treatments, the concept
of a polypill, which is a combination of
multiple
drugs
(aspirin,
angiotensin
converting enzyme (ACE) inhibitor, etc.) in a
single capsule, has been of recent interest.
The concept of polypills arose when experts
realized that although multiple different
medicines (e.g. antiplatelet agents, blood
pressure lowering agents, etc.) individually
served well in primary and secondary CVD
prevention, many other issues such as
adherence and access to these groups of
medicines could be improved through a
single capsule medication. Much research
today is now focused on developing and
improving these polypills due to promising
results from many past and ongoing clinical
trials in regards to improved medication
adherence and access.10 However, although
several of these polypills have become
available, many physicians, such as those in
India, have not been enthusiastic about using
them, likely due to their lack of patientspecificity.10

Policies and interventions for CVDs that can
be adopted and successfully implemented in
India have been an area of high focus. These
often target behavioral risk factors (tobacco
use, excessive alcohol intake, physical
inactivity, poor dietary consumption, etc.),
social determinants of health, and acute and
chronic CVD care. Success of these
interventions is dependent upon crosscollaboration between various industries
within the private and public sectors.
Policies involving tobacco regulation have
been effective in high-income countries,
leading to India passing the Cigarettes and
Other Tobacco Products Act (COTPA) in
2003, which includes prohibited public
smoking, mandated health advisory labels,
and restricted tobacco advertising.7 Other
food and environmental interventions that
have been implemented in India or shown
promising elsewhere for use in India include
increased taxation of different foods or
drinks, subsidies for fruits and vegetables,
and even usage of low-emission cooking
stoves. 8 9Other
general
policies
or
interventions that have been of interest
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Understanding India’s Challenges

challenging is the large regional and ethnic
diversity within the country. Differences in
biological risk factors, access to proper care,
adherence to treatments, and more may vary
between different groups and regions,
possibly due to religious, cultural, or social
differences. Further research and careful
consideration of these differences are critical
for successful implementation of new
interventions.

India’s rapidly growing population has led to
a major shortage of doctors, especially those
involved in cardiac care. Only around 4,000
cardiologists were registered as of 2013 with
the Cardiological Society of India (the largest
cardiologist organization) for a growing
population
of
nearly
1.3
billion
11 12
people
The government needs to further
develop
India’s
medical
education
infrastructure and reduce its associated
expenses to allow for more students to pursue
medicine and other health professions.
Moreover, a majority of hospitals and 74% of
graduate doctors are located in urban areas,
thereby serving only 28% of the Indian
population 13 These urban hospitals are very
expensive, making affordable care difficult
for many. This lack of doctors in rural areas
has led to increasing numbers of unqualified
providers prescribing and treating patients,
putting many lives at risk. Financial or other
incentives for investors, healthcare providers,
and hospitals are needed to promote further
expansion and development in rural areas.
What further makes tackling CVDs in India

Within India, social determinants have a
major impact on CVD diagnosis, outcomes,
and spending. The poor are more frequently
under-diagnosed, have reduced access to
proper care or medicines, and face a larger
financial burden from CVDs 14, 15 Those of
lower socioeconomic status (SES) are often
less likely to have successful outcomes and
receive different treatments compared to
those of higher SES. For example, acute
coronary syndrome patients of lower SES
received different and less effective
treatments than higher SES patients, which
also likely contributed to their greater
mortality rate.16 Policies that can reduce
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medical expenses to improve access to highquality care for all socioeconomic classes
will likely to lead to improved survival rates
and a reduced CVD burden.

Marching Forward
India’s growing population and large
socioeconomic disparities allow it to serve as
a strong model for implementing various
CVD policies in other low and middleincome
countries.
Successful
CVD
interventions in one of the most rapidly
growing countries in the world will reduce
the global health burden of CVDs and inspire
other countries to take great strides forward
as well. However, under-developed health
infrastructures and insufficient proper
resources make adoption of interventions and
policies that have worked in high-income
countries to lower and middle-income
countries difficult. Nonetheless, it is
imperative that India continues marching
forward and invests resources into tackling
the CVD epidemic in order to protect the
health of its citizens and bring great
prosperity to the country.
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